QUINACRINE ATTENUATES CYCLOSPORINE-INDUCED NEPHROTOXICITY IN RATS1
- 27 August 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 62 (4) , 427-435
- https://doi.org/10.1097/00007890-199608270-00001
Abstract
The biochemical mechanism underlying cyclosporine (CsA)* induced nephrotoxicity is far from clear. Increased generation of oxygen derived free radicals (ODFR) and enhanced activity of phospholipase A2(PLA2) have been observed in experimental animals following treatment with CsA. Several recent reports have shown that quinacrine, besides being a potent inhibitor of PLA2, suppresses the generation of ODFR. The present study was designed to investigate the effect of quinacrine on CsA induced nephrotoxicity in rats. Male Wistar rats (weighing 280-300 g) were randomized into eight groups of eight animals each. Group 1 (control) received appropriate vehicles only, whereas the rats in groups 2, 3, 4, and 5 received subcutaneous injection of CsA (17.5 mg/kg dissolved in olive oil) daily for 8 weeks. The animals in groups 3, 4, and 5 were also given intraperitoneal injections of quinacrine in three different doses of 2.5 mg/kg, 5 mg/kg, and 10 mg/kg body weight, respectively, in addition to CsA. The animals in groups 6, 7, and 8 received intraperitoneal injection of quinacrine alone at doses of 2.5 mg/kg, 5 mg/kg, and 10 mg/kg respectively for eight weeks. After 8 weeks, animals were sacrificed under light ether anesthesia and blood and kidney samples were collected for various biochemical and histological studies. The biochemical parameters included blood urea nitrogen (BUN), serum creatinine(Scr), potassium, and sodium. The blood was also analyzed for the level of CsA. The kidney samples were analyzed for malondialdehyde (MDA), glutathione, and vitamin E (VE). Kidney sections were prepared for histopathological studies using hematoxylin-eosin staining. There was an increase in BUN, Scr, and potassium levels and decrease in sodium levels in cyclosporine alone treated group, suggesting a significant nephrotoxicity. Quinacrine treatment significantly protected animals against CsA induced biochemical changes. Our studies on free radical indices showed that quinacrine treatment protected animals against cyclosporine induced increase in MDA and depletion of glutathione and VE. The beneficial effect of quinacrine against CsA induced nephrotoxicity was also confirmed by histological studies.Keywords
This publication has 49 references indexed in Scilit:
- Quinacrine inhibits oxygen radicals release from human alveolar macrophagesInternational Journal of Immunopharmacology, 1992
- High-performance liquid chromatographic analysis of lung phospholipids and their precursors in the offspring of diabetic ratsBiochemical Medicine and Metabolic Biology, 1990
- Cyclosporine a inhibits prostaglandin E2 release, and has no effect on renin secretion, from rat renal cortical slicesLife Sciences, 1990
- Lipid peroxidation and scavenger mechanism in experimentally induced heart infarctsBasic Research in Cardiology, 1985
- Influence of cyclosporin A on the respiration of isolated rat kidney mitochondriaFEBS Letters, 1985
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- Selective glutathione depletion on function and structure of the isolated perfused rat kidneyKidney International, 1983
- CYCLOSPORIN AND INTRAVENOUS SULPHADIMIDINE AND TRIMETHOPRIM THERAPYThe Lancet, 1983
- Vitamin E dependent reduced glutathione inhibition of rat liver microsomal lipid peroxidationLife Sciences, 1982
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981